Revision history of "Affected individual outcomes within myeloproliferative neoplasmrelated thrombosis Insights through the Countrywide Inpatient Trial"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 08:33, 22 March 2024Larchlilac73 (Talk | contribs). . (3,164 bytes) (+3,164). . (Created page with "6%, 2.A few mg/day 45.9%), Part 3 (A single mg/day 8.0%, 0.5 mg/day 7.3%) and imply day-to-day OFF-time (One mg/day 12.1%, Zero.Your five mg/day 8.4%). The effects of rasagili...")